// App-Quantinova.ai

54 : Real-world experience of pembrolizumab in microsatellite instability-high CRC: A Scottish multicenter analysis.

Researchers

Presenter

  • Aisha Ghaus

Principal Investigators

  • Ashley Pheely

  • Victoria Murdock

  • Hala Shareef

  • Leslie M. Samuel

  • Sally Clive

  • Fay Tough

  • Lisa Jane Rodgers

Medical Centers

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Edinburgh Cancer Research UK Centre, Edinburgh, United Kingdom

  • Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Ninewells Hospital Dundee, Dundee, United Kingdom

  • Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Western General Hospital, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Microsatellite instability-high

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved